Exploristics is now part of MMS

Bringing new depth to study design through integrated analytics and modeling

We look forward to delivering even greater value… through optimized strategies that reduce the overall time and cost burden in drug development.
Chris Schoonmaker
Chief Operating Officer at MMS

Exploristics, the Northern Ireland-based biostatistics and data science company, has officially joined MMS. This integration includes KerusCloud®, a leading trial simulation platform that strengthens our ability to support complex development programs.

Expanded Capabilities for Sponsors

With the addition of the Exploristics team, MMS has enhanced its European footprint and added greater depth in statistical innovation and clinical trial simulation. The KerusCloud platform allows sponsors to explore trial scenarios in advance and improve the likelihood of regulatory success while reducing unnecessary cost and delay.

Our combined expertise supports sponsors through early-phase planning, strategic design selection, and regulatory readiness across multiple regions.

Exploristics visitors are invited to explore how our combined teams deliver on complex clinical development challenges.

A Stronger Future Together

With KerusCloud and MMS biometrics teams fully aligned, the same focus on modeling, simulation, and quality remains. Now, it is paired with deeper regulatory strategy and full-service biometrics. Sponsors working with the Exploristics team can expect the same support they know, with added global infrastructure and strategic consulting capabilities from MMS.

Together, we remain focused on building high-quality submissions, designing successful trials, and meeting the growing demands of clinical research with clarity and consistency.

Let us know how we can support your next project